Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model.

View / Open Files

Published version (PDF, 3Mb)

Authors

Chatterjee, Diptaman

Bhatt, Mansi

Butler, David

De Genst, Erwin

Dobson, Christopher

Messer, Anne

Kordower, Jeffrey H

Publication Date

2018-01

Journal Title

NPJ Parkinson's disease

ISSN

2373-8057

Volume

4

Pages

25

Language

eng

Type

Article

Physical Medium

Electronic-eCollection

Metadata

Show full item record

Citation

Chatterjee, D., Bhatt, M., Butler, D., De Genst, E., Dobson, C., Messer, A., & Kordower, J. H. (2018). Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model.. NPJ Parkinson's disease, 4 25. https://doi.org/10.1038/s41531-018-0062-4

Identifiers

External DOI: https://doi.org/10.1038/s41531-018-0062-4

This record's URL: https://www.repository.cam.ac.uk/handle/1810/285645



Rights

Attribution 4.0 International

Licence URL: https://creativecommons.org/licenses/by/4.0/